A detailed history of Engineers Gate Manager LP transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Engineers Gate Manager LP holds 32,760 shares of FLGT stock, worth $585,421. This represents 0.01% of its overall portfolio holdings.

Number of Shares
32,760
Previous 17,555 86.61%
Holding current value
$585,421
Previous $344,000 106.69%
% of portfolio
0.01%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$19.6 - $25.06 $298,018 - $381,037
15,205 Added 86.61%
32,760 $711,000
Q2 2024

Aug 14, 2024

BUY
$19.09 - $22.57 $27,585 - $32,613
1,445 Added 8.97%
17,555 $344,000
Q1 2024

May 15, 2024

BUY
$21.55 - $29.29 $347,170 - $471,861
16,110 New
16,110 $349,000
Q4 2022

Feb 14, 2023

SELL
$29.23 - $40.28 $2,484 - $3,423
-85 Reduced 0.73%
11,501 $342,000
Q3 2022

Nov 14, 2022

SELL
$37.92 - $63.74 $46,793 - $78,655
-1,234 Reduced 9.63%
11,586 $442,000
Q2 2022

Aug 15, 2022

SELL
$47.98 - $62.75 $356,587 - $466,358
-7,432 Reduced 36.7%
12,820 $699,000
Q1 2022

May 16, 2022

BUY
$49.85 - $96.11 $1.01 Million - $1.95 Million
20,252 New
20,252 $1.26 Million
Q4 2021

Feb 14, 2022

SELL
$77.3 - $105.0 $290,029 - $393,960
-3,752 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$74.87 - $110.87 $280,912 - $415,984
3,752 New
3,752 $337,000
Q2 2021

Aug 16, 2021

SELL
$66.8 - $100.45 $913,156 - $1.37 Million
-13,670 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$59.3 - $183.85 $267,443 - $829,163
4,510 Added 49.24%
13,670 $1.32 Million
Q4 2020

Feb 16, 2021

BUY
$31.01 - $52.1 $284,051 - $477,236
9,160 New
9,160 $477,000

Others Institutions Holding FLGT

About Fulgent Genetics, Inc.


  • Ticker FLGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,265,800
  • Market Cap $541M
  • Description
  • Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...
More about FLGT
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.